Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sony Group Corp (SONY) vs Stryker Corporation (SYK) Price & Performance

Sony Group CorpTrade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Sony Group Corp vs Stryker Corporation — how do they compare? Sony Group Corp trades at $23.58 (market cap $138.72B), while Stryker Corporation trades at $276.3 (market cap $106.03B). The key difference: Sony Group Corp is the larger of the two by market cap, and Stryker Corporation pays the higher dividend (1.27%). Which is the better fit depends on your goals.

SONYSYK
Market Cap
$138.72B$106.03B
Sector
TechnologyTechnology
52-Week High
$30.26$388.79
52-Week Low
$19.32$275.39
Enterprise Value
$136.57B$117.50B
Dividend Yield
0.67%1.27%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Sony Group Corp

Sony trades at $23.53, down 4.19% over 24 hours amid bearish technical signals. The company maintains strong operational cash flow of $2.32 trillion for 2025 and has beaten earnings expectations in two of the last three quarters. Analyst consensus remains bullish with 11 buy ratings versus 5 holds, though recent news highlights Sony's legal actions against Anthropic for copyright infringement and strategic focus on organic expansion over large-scale acquisitions.

The outlook is mixed: solid fundamentals and analyst support suggest long-term value, but near-term technical weakness and a projected net income decline to -$221.6 billion for 2026 pose risks. Investment opportunity lies in Sony's diversified entertainment ecosystem and content moat, while key risks include execution on profitability targets and competitive pressures in streaming and gaming.

Stryker Corporation

Stryker (SYK) is trading at $276.43, down 8.81% over 24 hours, with a bearish technical signal from moving averages but bullish oscillators. The company reported mixed quarterly earnings, beating in Q4 2025 and Q2 2026 but missing in Q1 2026. Strong fundamentals include a net income margin of 14.43% and ROE of 16.51%, though valuation ratios like a P/E of 28.65 are elevated. Recent news includes a securities fraud investigation announcement and the launch of an FDA-cleared surgical app for Apple Vision Pro.

The outlook for SYK is supported by solid profitability and growth initiatives like acquisitions and product launches, but near-term risks include the fraud investigation and competitive pressures. Analyst consensus is strongly bullish with a $376 price target, suggesting significant upside potential if the company navigates current challenges successfully.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Sony Group Corp

Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is a global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with six major business segments. The company fully consolidated Sony Financial in September 2020, which provides life and non-life insurance, banking, and other financial services.

Read more on SONY

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK